Macrophage-produced IL-12p70 mediates hemorrhage-induced damage in a complement-dependent manner

Shock

Volumn 35, Issue 2, 2011, Pages 134-140

  Hylton, Diana J ^a   Hoffman, Sara M ^a   Van Rooijen, N ^b   Tomlinson, Stephen ^c   Fleming, Sherry D ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

complement inhibitor; cytokines; Inflammation; intestine; mouse

Indexed keywords

CLODRONIC ACID; COMPLEMENT INHIBITOR; COMPLEMENT RECEPTOR 2 FACTOR H; INTERLEUKIN 12P40; INTERLEUKIN 12P70; LEUKOTRIENE B4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CELL INFILTRATION; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; INNATE IMMUNITY; INTESTINE INJURY; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; CLODRONIC ACID; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATING AGENTS; COMPLEMENT SYSTEM PROTEINS; IMMUNITY, INNATE; INTERLEUKIN-12; INTESTINAL DISEASES; INTESTINES; LEUKOTRIENE B4; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; SHOCK, HEMORRHAGIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78751638084     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181ed8ec9     Document Type: Article

References (35)

1. Cohen MJ, Brohi K, Calfee CS, Rahn P, Chesebro BB, Christiaans SC, Carles M, Howard M, Pittet JF: Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care 13:R174, 2009.
2. Clark JA, Coopersmith CM: Intestinal crosstalk: a new paradigm for understanding the gut as the Bmotor[ of critical illness. Shock 28:384-393, 2007.
3. Fleming SD, Phillips LM, Lambris JD, Tsokos GC: Complement component C5a mediates hemorrhage-induced intestinal damage. J Surg Res 150:196-203, 2008.
4. Frink M, Hsieh YC, Hsieh CH, Pape HC, Choudhry MA, Schwacha MG, Chaudry IH: Keratinocyte-derived chemokine plays a critical role in the induction of systemic inflammation and tissue damage after trauma-hemorrhage. Shock 28:576-581, 2007.
5. Fan J, Li Y, Vodovotz Y, Billiar TR, Wilson MA: Hemorrhagic shock-activated neutrophils augment TLR4 signalingYinduced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. Am J Physiol 290:L738YL746, 2006.
6. Hildebrand F, Hubbard WJ, Choudhry MA, Frink M, Pape HC, Kunkel SL, Chaudry IH: Kupffer cells and their mediators: the culprits in producing distant organ damage after trauma-hemorrhage. Am J Pathol 169:784-794, 2006.
7. Hildebrand F, Thobe BM, Hubbard WJ, Choudhry MA, Pape HC, Chaudry IH: Effects of 17beta-estradiol and flutamide on splenic macrophages and spleno-cytes after trauma-hemorrhage. Cytokine 36:107-114, 2006.
8. Jarrar D, Kuebler JF, Rue LW 3rd, Matalon S, Wang P, Bland KI, Chaudry IH: Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappaB and MAPK/ERK mechanisms. Am J Physiol Lung Cell Mol Physiol 283:L799YL805, 2002. 9.
9. Younger JG, Sasaki N, Waite MD, Murray HN, Saleh EF, Ravage ZA, Hirschl RB, Ward PA, Till GO: Detrimental effects of complement activation in hemorrhagic shock. J Appl Physiol 90:441-446, 2001.
10. Holers VM, Thurman JM: The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol Immunol 41:147-152, 2004.
11. Holers VM: The spectrum of complement alternative pathwayYmediated diseases. Immunol Rev 223:300-316, 2008.
12. Hylton DJ, Phillips LM, Hoffman SM, Fleming SD: Hemorrhage-induced intestinal damage is complement independent in Helicobacter-hepaticus infected mice. Shock 34(5):467-474, 2010.
13. Huang Y, Qiao F, Atkinson C, Holers VM, Tomlinson S: A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. J Immunol 181:8068-8076, 2008.
14. Frink M, Hsieh YC, Thobe BM, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH: TLR4 regulates Kupffer cell chemokine production, systemic inflammation and lung neutrophil infiltration following trauma-hemorrhage. Mol Immunol 44:2625-2630, 2007.
15. Hierholzer C, Kalff JC, Billiar TR, Bauer AJ, Tweardy DJ, Harbrecht BG: Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock. Am J Physiol 286:G225YG233, 2004.
16. Mees ST, Toellner S, Marx K, Faendrich F, Kallen KJ, Schroeder J, Haier J, Kahlke V: Inhibition of interleukin-6Ytranssignaling via gp130-Fc in hemor-rhagic shock and sepsis. J Surg Res 157:235-242, 2009.
17. Ertel W, Morrison MH, Ayala A, Chaudry IH: Biological significance of elevated TNF levels: in vivo administration of monoclonal antibody against TNF following haemorrhage shock increases the capacity of macrophages to release TNF while restoring immunoresponsiveness. Cytokine 6:624-632, 1994.
18. Ertel W, Morrison MH, Ayala A, Perrin MM, Chaudry IH: Anti-TNF monoclonal antibodies prevent haemorrhage-induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression. Immunology 74:290-297, 1991.
19. Holscher C: The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immunol 193:1-17, 2004.
20. Rajnik M, Salkowski CA, Thomas KE, Li YY, Rollwagen FM, Vogel SN: Induction of early inflammatory gene expression in a murine model of non-resuscitated, fixed-volume hemorrhage. Shock 17:322-328, 2002.
21. Fleming SD, Shea-Donohue T, Guthridge JM, Kulik L, Waldschmidt TJ, Gip-son MG, Tsokos GC, Holers VM: Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169:2126-2133, 2002.
22. Van Rooijen N, Sanders A: Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and eth-ylenediaminetetraacetic acid. Hepatology 23:1239-1243, 1996.
23. van Rooijen N, van Kesteren-Hendrikx E: BIn vivo[ depletion of macrophages by liposome-mediated Bsuicide[. Methods Enzymol 373:3-16, 2003.
24. Halpern MD, Holubec H, Dominguez JA, Williams CS, Meza YG, McWilliam DL, Payne CM, McCuskey RS, Besselsen DG, Dvorak B: Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 51:733-739, 2002.
25. Neta R, Stiefel SM, Ali N: In lethally irradiated mice interleukin-12 protects bone marrow but sensitizes intestinal tract to damage from ionizing radiation. Ann N Y Acad Sci 762:274-280; discussion 280-281, 1995.
26. + T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. Clin Immunol 130:313-321, 2009.
27. Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, Sato T, Sakuraba A, Kitazume MT, Sugita A, Koganei K, et al.: Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest 118:2269-2280, 2008.
28. Fruchterman TM, Spain DA, Wilson MA, Harris PD, Garrison RN: Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. Surgery 124:782-792, 1998.
29. Heller T, Hennecke M, Baumann U, Gessner JE, zu Vilsendorf AM, Baensch M, Boulay F, Kola A, Klos A, Bautsch W, et al.: Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury. J Immunol 163: 985-994, 1999.
30. Horstick G, Kempf T, Lauterbach M, Bhakdi S, Kopacz L, Heimann A, Malzahn M, Horstick M, Meyer J, Kempski O: C1-esteraseYinhibitor treatment at early reperfusion of hemorrhagic shock reduces mesentery leukocyte adhesion and rolling. Microcirculation 8:427-433, 2001.
31. Peckham RM, Handrigan MT, Bentley TB, Falabella MJ, Chrovian AD, Stahl GL, Tsokos GC: C5-blocking antibody reduces fluid requirements and improves responsiveness to fluid infusion in hemorrhagic shock managed with hypotensive resuscitation. J Appl Physiol 102:673-680, 2007.
32. Banda NK, Levitt B, Glogowska MJ, Thurman JM, Takahashi K, Stahl GL, Tomlinson S, Arend WP, Holers VM: Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibodyYinduced arthritis in mice. J Immunol 183:5928-5937, 2009.
33. Smith PD, Ochsenbauer-Jambor C, Smythies LE: Intestinal macrophages: unique effector cells of the innate immune system. Immunol Rev 206:149-159, 2005.
34. + T cells after trauma-hemorrhage reduces T-cell function: a mechanism of post-traumatic immune suppression. Am J Pathol 175: 1504-1514, 2009.
35. Cooper AM, Khader SA: IL-12p40: an inherently agonistic cytokine. Trends Immunol 28:33-38, 2007.